Stay updated on Tagraxofusp in Secondary AML Clinical Trial

Sign up to get notified when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tagraxofusp in Secondary AML Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page’s revision identifier changes from **v3.5.2** to **v3.5.3**, indicating an update to the record-history page tooling/label rather than a modification of the clinical trial’s record details.
    Difference
    0.1%
    Check dated 2026-04-24T06:31:12.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 was added to the history, replacing the prior v3.5.0. The previous revision v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:52:57.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    New version entry dated 2026-04-08 adds Study Status updates; the history entry dated 2026-01-23 has been removed.
    Difference
    0.3%
    Check dated 2026-04-09T21:49:08.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    A new revision entry v3.5.0 was added to the Record History, and the previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:48:54.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 to the record history and removed Revision: v3.4.2 from the history.
    Difference
    0.1%
    Check dated 2026-03-12T02:20:38.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history page. The prior notices about government funding and operating status (v3.4.1) were removed.
    Difference
    0.6%
    Check dated 2026-02-11T12:38:27.000Z thumbnail image

Stay in the know with updates to Tagraxofusp in Secondary AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.